Nanotechnology for diagnosis, imaging, and treatment of head and neck cancer
Early Detection and Treatment of Head & Neck Cancers: Practical Applications and Techniques for Detection, Diagnosis, and Treatment, Page: 63-120
2021
- 1Citations
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
The emergence of nanotechnology has revolutionized many fields including chemistry, physics, engineering, biology, and medicine. The advent of nanotechnology-based nanomedicine including nanoparticles, nanocarriers, and nanoprobes is promising. However, the application of such materials in particular in cancer management is at an early stage of development. The knowledge about the basic mechanism of interactions of nanoparticles at molecular and cellular levels is not appropriate to disclose their full potential in biology and medicine. Furthermore, despite numerous clinical trials, the translational flow into clinical fields is very limited. This chapter sheds light on a new and challenging topic related to the management of head and neck cancer (HNC) through the application of nanotechnology. A general overview is provided about the available nanoparticles, their classification, and their pathway mechanisms into tumors. Finally, we made an effort to highlight the current nanotechnology-based strategies and active clinical trials targeting HNC.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85150127351&origin=inward; http://dx.doi.org/10.1007/978-3-030-69859-1_4; https://link.springer.com/10.1007/978-3-030-69859-1_4; https://dx.doi.org/10.1007/978-3-030-69859-1_4; https://link.springer.com/chapter/10.1007/978-3-030-69859-1_4
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know